William Blair & Company
GNMK

William Blair & Company’s GenMark Diagnostics, Inc GNMK Stock Holding History

William Blair & Company’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-46,984
Closed -$686K – 1927
2020
Q4 		$686K Sell
46,984
-3,450
-7% -$45.7K ﹤0.01% 991
2020
Q3 		$716K Buy
50,434
+3,650
+8% +$55.8K ﹤0.01% 862
2020
Q2 		$688K Hold
46,784
– – ﹤0.01% 846
2020
Q1 		$193K Sell
46,784
-500
-1% -$2.34K ﹤0.01% 1175
2019
Q4 		$227K Sell
47,284
-29,550
-38% -$163K ﹤0.01% 1263
2019
Q3 		$466K Sell
76,834
-16,432
-18% -$103K ﹤0.01% 974
2019
Q2 		$605K Hold
93,266
– – ﹤0.01% 921
2019
Q1 		$661K Hold
93,266
– – ﹤0.01% 863
2018
Q4 		$453K Hold
93,266
– – ﹤0.01% 939
2018
Q3 		$686K Sell
93,266
-3,000
-3% -$22K ﹤0.01% 855
2018
Q2 		$614K Hold
96,266
– – ﹤0.01% 880
2018
Q1 		$524K Buy
96,266
+3,000
+3% +$14.9K ﹤0.01% 910
2017
Q4 		$389K Buy
93,266
+48,849
+110% +$294K ﹤0.01% 1048
2017
Q3 		$428K Buy
+44,417
New +$461K ﹤0.01% 986

Other funds holding GNMK

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair & Company's GNMK Position: Q1 2021 in Review

William Blair & Company sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2021, closing a stake of 46,984 shares — an estimated $686K sold.

William Blair & Company first reported a position in GNMK in Q3 2017 and held it in 14 quarters. The position peaked at $716K in Q3 2020. 164 funds tracked by Wall St. Rank hold GNMK as of Q1 2021.

  • William Blair & Company reported no remaining GenMark Diagnostics, Inc position as of Q1 2021 after selling out during the quarter.
  • William Blair & Company sold 46,984 GenMark Diagnostics, Inc shares in Q1 2021, an estimated $686K.
  • William Blair & Company first reported a position in GenMark Diagnostics, Inc in Q3 2017 and held it in 14 quarters.
  • William Blair & Company's GenMark Diagnostics, Inc position peaked at $716K in Q3 2020.
  • 164 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2021.

Based on William Blair & Company's 13F filing for Q1 2021, filed 13 May 2021.